MUFG in Talks to Arrange New Debt Swaps After $465 Million Deal
Japan's biggest bank is looking to expand its presence in the market for debt swaps after helping to wrap up a €400 million ($465 million) deal for Ivory Coast in December. Following that transaction, MUFG is now 'engaging with a number of borrowers on similar structures,' Ankit Khandelwal, the bank's head of Africa sovereigns, development finance institutions and blended finance, said in an interview.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Caledonia (CMCL) Reports Record Q2 Production at Blanket, Raises Annual Guidance
Caledonia Mining Corporation Plc (NYSEAMERICAN:CMCL) is one of the 13 Most Promising Gold Stocks According to Wall Street Analysts. On July 16, Caledonia Mining Corporation Plc (NYSEAMERICAN:CMCL) shared its gold production numbers from the Blanket Mine in Zimbabwe for the second quarter and the first half of 2025. The company also raised its annual production guidance. In the second quarter of 2025, Caledonia Mining Corporation Plc (NYSEAMERICAN:CMCL) reported gold production was 21,070 ounces, which is a new second-quarter record. For the first half of 2025, gold production reached 39,741 ounces. This represents an increase of 5.1 % compared to the first half of 2024. Drills extracting gold from a gold mine, revealing the company's gold mining operation. Caledonia Mining Corporation Plc (NYSEAMERICAN:CMCL) said the production in the first half was very good and exceeded expectations. Because of this strong performance, the company increased its gold production guidance for 2025. The company now expects Blanket Mine to produce between 75,500 and 79,500 ounces of gold in 2025. Caledonia Mining Corporation Plc (NYSEAMERICAN:CMCL) believes the mine continues to provide a solid foundation for growth. Caledonia Mining Corporation Plc (NYSEAMERICAN:CMCL) is a gold-producing company focused on Zimbabwe. The company's main asset is the Blanket Mine. While we acknowledge the potential of CMCL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 12 Best Performing AI Stocks So Far in 2025 and 14 Best Aggressive Growth Stocks to Buy According to Analysts. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
Middle Eastern Penny Stocks: Gulf Pharmaceutical Industries P.S.C And Two More To Watch
The Middle Eastern stock markets have been experiencing mixed performances, with some indices buoyed by hopes of a U.S. Federal Reserve rate cut while others are weighed down by weaker corporate earnings. In this context, penny stocks—though an older term—remain relevant as they often represent smaller or less-established companies that can offer significant value when backed by strong financials. This article will highlight three such penny stocks in the Middle East, focusing on their potential for long-term growth and stability amidst current market conditions. Top 10 Penny Stocks In The Middle East Name Share Price Market Cap Financial Health Rating Big Tech 50 R&D-Limited Partnership (TASE:BIGT) ₪1.414 ₪15M ★★★★★★ Thob Al Aseel (SASE:4012) SAR3.71 SAR1.48B ★★★★★★ Mega Polietilen Köpük Sanayi ve Ticaret Anonim Sirketi (IBSE:MEGAP) TRY4.75 TRY1.31B ★★★★★☆ E7 Group PJSC (ADX:E7) AED1.47 AED3B ★★★★★★ Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR) TRY2.97 TRY3.2B ★★★★★☆ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.45 AED392.7M ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.89 AED12.25B ★★★★☆☆ Al Dhafra Insurance Company P.S.C (ADX:DHAFRA) AED4.86 AED486M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.828 AED488.43M ★★★★★★ Tgi Infrastructures (TASE:TGI) ₪2.937 ₪218.34M ★★★★★★ Click here to see the full list of 76 stocks from our Middle Eastern Penny Stocks screener. Here's a peek at a few of the choices from the screener. Gulf Pharmaceutical Industries P.S.C Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Gulf Pharmaceutical Industries P.S.C., also known as Julphar, manufactures and sells a range of pharmaceutical, cosmetic, and medical products in the UAE, GCC countries, and internationally with a market cap of AED1.68 billion. Operations: The company's revenue segments include AED732.9 million from Planet and AED864.9 million from Manufacturing. Market Cap: AED1.68B Gulf Pharmaceutical Industries P.S.C., known as Julphar, has shown a positive shift in its financial performance, reporting a net income of AED 157.9 million for the first half of 2025 compared to a net loss the previous year. The company's debt is well-managed with operating cash flow covering 31.1% and a reduced debt-to-equity ratio from 117% to 55.9% over five years, indicating improved financial health. Despite low return on equity at 2.4%, Julphar's profitability and stable weekly volatility are promising traits for investors interested in Middle Eastern penny stocks with potential growth prospects amidst operational challenges. Get an in-depth perspective on Gulf Pharmaceutical Industries P.S.C's performance by reading our balance sheet health report here. Examine Gulf Pharmaceutical Industries P.S.C's earnings growth report to understand how analysts expect it to perform. Sinpas Gayrimenkul Yatirim Ortakligi Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Sinpas Gayrimenkul Yatirim Ortakligi, originally established as Sinpas Insaat Anonim Sirketi in 2006 and transformed into a Real Estate Investment Trust (REIT) in 2007, operates in the real estate sector with a market capitalization of TRY17.76 billion. Operations: The company generates revenue primarily from its Residential Real Estate Developments segment, amounting to TRY12.64 billion. Market Cap: TRY17.76B Sinpas Gayrimenkul Yatirim Ortakligi has demonstrated robust financial health, with short-term assets of TRY14.8 billion comfortably covering both its short and long-term liabilities. The company has experienced significant earnings growth, notably an 86.4% increase over the past year, surpassing industry averages. However, a substantial one-off gain of TRY5.3 billion skews recent earnings quality. While its net debt to equity ratio is satisfactorily low at 14.2%, interest coverage remains weak at 2.1 times EBIT, suggesting potential pressure in meeting debt obligations despite stable weekly volatility and reduced debt levels over five years. Unlock comprehensive insights into our analysis of Sinpas Gayrimenkul Yatirim Ortakligi stock in this financial health report. Review our historical performance report to gain insights into Sinpas Gayrimenkul Yatirim Ortakligi's track record. Oil Refineries Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Oil Refineries Ltd. operates in the production and sale of fuel products, intermediate materials, and aromatic products both in Israel and internationally, with a market cap of ₪2.64 billion. Operations: Currently, there are no reported revenue segments for Oil Refineries Ltd. Market Cap: ₪2.64B Oil Refineries Ltd. faces challenges with a net loss of US$37 million in Q2 2025, contrasting with a profit last year. Despite this, its financial structure shows resilience; short-term assets of US$2 billion surpass both short and long-term liabilities. While the dividend yield is high at 10.22%, it isn't supported by earnings, raising sustainability concerns. Debt management has improved over five years, reducing from 127.7% to 75.3%. However, interest payments remain uncovered by EBIT and the company remains unprofitable despite shrinking losses annually by 25.8%. Management's experience offers some stability amid these hurdles. Dive into the specifics of Oil Refineries here with our thorough balance sheet health report. Explore historical data to track Oil Refineries' performance over time in our past results report. Turning Ideas Into Actions Click here to access our complete index of 76 Middle Eastern Penny Stocks. Interested In Other Possibilities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:JULPHAR IBSE:SNGYO and TASE:ORL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
an hour ago
- Yahoo
Kodak's corporate doom: 133-year-old photo icon warns investors it may cease operations with $500 million debt problem
After 133 years, a bankruptcy, and multiple reinventions, Kodak's latest snapshot is grim: The company says there's 'substantial doubt' it can stay in business. In a quarterly filing released Monday alongside its second-quarter earnings report, Kodak's management raised serious concerns about its ability to continue operating over the next year. The warning stems from roughly $500 million in debt maturing within 12 months and the lack of committed financing to cover those obligations. Without new funding or successful refinancing, the company could default, they said. The note's stark language sent Kodak's shares tumbling, sliding 21% to $5.43 as of Wednesday morning. Deep strains in earnings For the second quarter ended June 30, Kodak booked $263 million in revenue, which was down 1% from a year earlier. However, the real blow came from the bottom line: Profitability took a sharp hit compared to last quarter, with gross profit sinking 12% to $51 million, squeezing Kodak's margins from 22% to 19%. What had been a $26 million profit in the same period last year flipped 180 degrees to a $26 million loss. Operational EBITDA slipped to $9 million from $12 million, as significantly lower sales volumes and surging manufacturing costs overwhelmed relatively modest price increases. Cash reserves also slimmed down. Kodak ended the quarter with $155 million on hand, just $70 million of it in the U.S. That's $46 million less than it had in December, drained by rising costs, and weaker operating results. Chief financial officer David Bullwinkle said in the note the company is counting on a somewhat random source of liquidity: terminating its U.S. Kodak Retirement Income Plan and using excess assets to pay down debt. Kodak said it expects clarity by mid-August on how it will settle obligations to plan participants, and aims to complete the process by December. Dave Zhang, a printing industry expert from analyst group WhatTheyThink, said Kodak's pain isn't unique. 'Every major equipment manufacturer in commercial printing is feeling the same squeeze this year, in the U.S. and in Europe,' Zhang told Fortune. 'Customers are holding back on big buys unless they absolutely have to. Tariffs and economic uncertainty aren't giving them the warm-and-fuzzy to invest.' Kodak's long fall Founded by George Eastman in the late 19th century, Kodak revolutionized photography by democratizing film, making cameras affordable for the masses. Its slogan—'You push the button, we do the rest'—became synonymous with convenient sentimentality. At its peak in the 1970s, Kodak controlled nearly 90% of U.S. film sales and 85% of the camera market. Then the digital revolution upended the industry, and Kodak stumbled. In a twist of irony, it was a Kodak engineer who created the first digital camera—but, fearing the innovation would cannibalize their current product, the company sat on the invention. They bet on film being a source of nostalgia, even as digital cameras took over the market with a promise of even more convenience. By 2012, saddled with billions in debt, Kodak filed for Chapter 11 bankruptcy. However, Zhang traced the decay back even earlier, to the mid-2000s, when then-CEO Antonio Pérez 'basically decimated' Kodak's chemical and film manufacturing—'the company's roots'—laying off tens of thousands and selling off or destroying key facilities. 'Don't throw out the baby with the bathwater,' Zhang warned. 'They blew their future.' When current CEO Jim Continenza took over, his job was to steer Kodak out of bankruptcy and rebuild its core. 'It's not just about nostalgia film,' the analyst said. 'They've had to rebuild a film line from scratch—equipment you can't just order on Amazon—and now they're at full manufacturing capacity.' Kodak's film output today includes industrial products like films for automotive components, not just 35mm rolls. Additionally, Kodak shifted from its consumer camera business to focus on commercial printing, packaging, and specialty chemicals. In recent years, it has sought growth in advanced materials, including film for the movie industry and components for pharmaceuticals. In fact, the pharmaceutical pivot was so successful that the day Kodak secured a government loan to pursue manufacturing, their stock soared so quickly it broke circuit breakers. Kodak has also leaned into nostalgia with hundreds of brick-and-mortar retail stores, which are particularly popular internationally. Despite the brand's trendiness, Timothy Calkins, a marketing professor at the Kellogg School of Management at Northwestern University, told The New York Times he found the trademark licensing 'striking'' and 'sad,' suggesting a sense of desperation in the Kodak brand. An uncertain path forward Kodak does have one bright spot from its second-quarter earnings: its Advanced Materials & Chemicals division saw revenue grow, and the company also recently secured FDA registration for a new pharmaceutical manufacturing facility, allowing it to produce regulated products. CEO Jim Continenza framed the development as part of Kodak's transformation into a manufacturer with diversified products. 'We continue to accelerate the growth of our Advanced Materials & Chemicals business,' he wrote in the earnings release, adding that U.S. manufacturing capacity could help shield Kodak from potential tariff shocks. The question is whether that shield will be strong enough. The going-concern disclosure, near the end of the earnings report, makes clear that Kodak's plans to right the ship—pension reversion, debt restructuring, and refinancing—are not entirely within its control. U.S. accounting rules require such a warning when management cannot conclude those steps are 'probable.' 'They need time and money,' Zhang said. 'Time is hard to get, but if they can get the money, they might just rebuild this thing.' For now, investors are wondering if the company can improbably reinvent itself for the second, third, or fourth time, or if this is the long-awaited fade-out of a company that once defined how the world captured its memories. This story was originally featured on Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
